Oman · Delayed Price · Currency is OMR Renaissance Services SAOG Statistics
Total Valuation
MSM:RNSS has a market cap or net worth of OMR 70.45 million. The enterprise value is 122.61 million.
| Market Cap | 70.45M |
| Enterprise Value | 122.61M |
Important Dates
The next estimated earnings date is Tuesday, July 14, 2026.
| Earnings Date | Jul 14, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
MSM:RNSS has 213.47 million shares outstanding. The number of shares has decreased by -0.15% in one year.
| Current Share Class | 213.47M |
| Shares Outstanding | 213.47M |
| Shares Change (YoY) | -0.15% |
| Shares Change (QoQ) | -1.45% |
| Owned by Insiders (%) | 11.12% |
| Owned by Institutions (%) | 0.13% |
| Float | 162.36M |
Valuation Ratios
The trailing PE ratio is 12.32 and the forward PE ratio is 13.58.
| PE Ratio | 12.32 |
| Forward PE | 13.58 |
| PS Ratio | 0.66 |
| PB Ratio | 0.71 |
| P/TBV Ratio | 0.87 |
| P/FCF Ratio | 4.38 |
| P/OCF Ratio | 3.87 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.25, with an EV/FCF ratio of 7.62.
| EV / Earnings | 21.50 |
| EV / Sales | 1.16 |
| EV / EBITDA | 7.25 |
| EV / EBIT | 15.54 |
| EV / FCF | 7.62 |
Financial Position
The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.63.
| Current Ratio | 1.20 |
| Quick Ratio | 1.07 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | 3.75 |
| Debt / FCF | 3.94 |
| Interest Coverage | 2.10 |
Financial Efficiency
Return on equity (ROE) is 3.92% and return on invested capital (ROIC) is 4.28%.
| Return on Equity (ROE) | 3.92% |
| Return on Assets (ROA) | 2.35% |
| Return on Invested Capital (ROIC) | 4.28% |
| Return on Capital Employed (ROCE) | 5.40% |
| Weighted Average Cost of Capital (WACC) | 3.96% |
| Revenue Per Employee | 12,962 |
| Profits Per Employee | 698 |
| Employee Count | 8,173 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 19.62 |
Taxes
In the past 12 months, MSM:RNSS has paid 1.28 million in taxes.
| Income Tax | 1.28M |
| Effective Tax Rate | 24.60% |
Stock Price Statistics
The stock price has increased by +15.79% in the last 52 weeks. The beta is -0.13, so MSM:RNSS's price volatility has been lower than the market average.
| Beta (5Y) | -0.13 |
| 52-Week Price Change | +15.79% |
| 50-Day Moving Average | 0.38 |
| 200-Day Moving Average | 0.33 |
| Relative Strength Index (RSI) | 10.77 |
| Average Volume (20 Days) | 91,476 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MSM:RNSS had revenue of OMR 105.94 million and earned 5.70 million in profits. Earnings per share was 0.03.
| Revenue | 105.94M |
| Gross Profit | 13.85M |
| Operating Income | 7.89M |
| Pretax Income | 5.20M |
| Net Income | 5.70M |
| EBITDA | 16.73M |
| EBIT | 7.89M |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 27.98 million in cash and 63.33 million in debt, with a net cash position of -35.35 million or -0.17 per share.
| Cash & Cash Equivalents | 27.98M |
| Total Debt | 63.33M |
| Net Cash | -35.35M |
| Net Cash Per Share | -0.17 |
| Equity (Book Value) | 99.82M |
| Book Value Per Share | 0.39 |
| Working Capital | 11.76M |
Cash Flow
In the last 12 months, operating cash flow was 18.20 million and capital expenditures -2.12 million, giving a free cash flow of 16.08 million.
| Operating Cash Flow | 18.20M |
| Capital Expenditures | -2.12M |
| Depreciation & Amortization | 8.84M |
| Net Borrowing | -5.87M |
| Free Cash Flow | 16.08M |
| FCF Per Share | 0.08 |
Margins
Gross margin is 13.08%, with operating and profit margins of 7.45% and 5.38%.
| Gross Margin | 13.08% |
| Operating Margin | 7.45% |
| Pretax Margin | 4.90% |
| Profit Margin | 5.38% |
| EBITDA Margin | 15.79% |
| EBIT Margin | 7.45% |
| FCF Margin | 15.18% |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 9.09%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 9.09% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 112.48% |
| Buyback Yield | 0.15% |
| Shareholder Yield | 9.24% |
| Earnings Yield | 8.10% |
| FCF Yield | 22.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for MSM:RNSS is 0.37, which is 12.12% higher than the current price. The consensus rating is "Hold".
| Price Target | 0.37 |
| Price Target Difference | 12.12% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 5.51% |
| EPS Growth Forecast (3Y) | 2.11% |
Stock Splits
The last stock split was on January 21, 2020. It was a reverse split with a ratio of 0.6436911827.
| Last Split Date | Jan 21, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.6436911827 |
Scores
MSM:RNSS has an Altman Z-Score of 1.33 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.33 |
| Piotroski F-Score | 5 |